Non-Melanoma Skin Cancers Coverage from Every Angle
Advertisement
Advertisement

Chrysalyne Schmults, MD, on Basal Cell Carcinoma: Treatment Research Update

Posted: Saturday, March 23, 2019

Chrysalyne Schmults, MD, of Brigham and Women’s Hospital, discusses an update on the use of hedgehog pathway inhibitors such as vismodegib and sonidegib in the treatment of basal cell carcinoma and the status of other agents under study for this type of skin cancer.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.